ATTENUATED EFFECT OF GROWTH HORMONE(GH) IN ACIDOSIS- AND METHYLPREDNISONE(MP)-INDUCED GROWTH RETARDATION(GR) IN WEANLING RATS

Abstract

Acidosis and glucocorticoid excess retard linear growth. GH reverses MP-induced GR and stimulates urinary net acid excretion in mid-sized uremic rats. However, the efficacy of GH in reversing acidosis- and MP-induced GR in early postnatal life is unknown. We gave GH (0.5mg.s.c. 5d/wk × 2wk) to NH₄Cl-treated(0.28M), MP-treated (6mg/kg/day), and control(H₂O) weanling Sprague-Dawley rats (mean wt. 50gm) and to adult (A)(mean wt: 250gm) NH₄CL-treated and control rats. Acidosis was confirmed by a mean venous pH of 7.26±.03 in NH₄CL animals. Pair feeding (PF), matching food intake to NH₄CL rats, was examined in a subset of weanling-and A-H₂O rats. Compared with non-PF weanling H₂O rats, who had change in length (d-It[cm]) of 5.68±0.07, linear growth was retarded (p<0.05) by NH₄CL (d-lt 4.32±0.8), MP (d-lt 4.62±0.1), and PF (d-lt 4.63±0.05). PF markedly reduced weight gain (d-wt[gm]) in H₂O rats (38±4 PF vs. 91±12 non-PF). In A rats, NH₄CL diminished d-lt (2.64±0.25 vs. [A-H₂O] 3.17±0.2) but PF did not. GH treatment did not accelerate growth in weanling NH₄CL, MP, or H₂O rats. In contrast, GH did increase d-lt in A-NH₄CL rats (2.65±0.25 vs. 2.12±0.1; p<0.05). We conclude: 1) GH ameliorates acidosis-induced GR in A rats; 2) poor caloric intake accounts for much of acidosis-induced GR in weanling rats; 3) the efficacy of GH in reversing GR in acidosis- or MP-induced GR is limited in very young animals. These results suggest that rapid early linear growth in weanling rats is not primarily GH-dependent, and that neonatal GR due to acidosis or glucocorticoid excess results predominantly from mechanisms other than impaired GH secretion and action.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account

Continue with Google

Continue with ORCiD